Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10

Aujourd'hui

16:30
Angion Biomedica and Sinovant Sciences today announced a collaboration and license agreement for BB3, Angion's investigational small molecule mimetic of hepatocyte growth factor (HGF), in the People's Republic of China, Hong Kong, Macau, and Taiwan...

16:00
Amgen today announced the final report of the Open-Label Study of Long-TERm Evaluation Against LDL-C (OSLER-1), demonstrating long-term treatment with Repatha® (evolocumab) was associated with robust and consistent reductions in low-density...

15:45
There are less than 12 weeks until the 15th Annual WORLDSymposium 2019 Research Congress dedicated to lysosomal diseases. The annual research meeting, taking place 4th ? 8th February 2019 in Orlando, Florida, is now accepting late-breaking abstract...

14:51
Pharmazz, Inc., today announced that data from the Phase 2 clinical study in patients with hypovolemic shock, were presented in the Drug Discovery-Heart Failure Oral Abstracts Session II at the American Heart Association Scientific Sessions in...

14:48
Northern Green Canada Inc. (NGC) commissioned Cannabis Research Associates (CRA), in co-operation with their R&D subsidiary company Northern Green Sciences (NGS) to conduct a multi-phase study Cannabis For Opioid Substitution Trial (COST) approved by...

13:09
Feinstein Institute for Medical Research Professor David Eidelberg, MD, won the fourth annual Bachmann-Strauss Prize for Excellence in Dystonia Research. Dr. Eidelberg received an unrestricted $100,000 grant for his use of innovative brain imaging...

13:03
Two Abstracts Featuring Perspectum Diagnostics' MRCP+ Accepted for Presentation at The Liver Meeting® 2018  The clinical utility of quantitative metrics produced by MRCP+ for discriminating biliary disease was the focus of several abstracts accepted...

12:00
Royal Philips , a global leader in health technology, today announced enrollment of the first U.S. patient in the Stellarex ILLUMENATE Below-the-Knee (BTK) Investigational Device Exemption (IDE) study, led by principal investigators Dr. Bill Gray and...

11:55
The disruptive innovation for autonomous management of T1D   Diabeloop announced today it has received the CE marking for the DBLG1tm, its innovative technological solution to radically improve quality of life for T1D patients through better blood...

11:48
Intervention chirurgicale effectuée au NYU Langone Orthopedic Hospital à New York par un chirurgien de la médecine du sport, Eric Strauss, MD    CartiHeal, le développeur d'Agili-C, un implant exclusif destiné au traitement des lésions de la...

11:00
An experimental drug may be effective against a deadly form of pancreatic cancer when used in combination with other immune-boosting therapies, according to a cover study publishing online Nov. 12 in Cancer Cell. The findings revolve around the...

10:58
The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced David Eidelberg, MD, professor and head of the Feinstein Institute for Medical Research's Center for Neurosciences and professor of Molecular Medicine and Neurology at the Donald...

10:46
PolyPid Ltd., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, locally administered therapies for post-surgical complications, announced today that the United States Food and Drug Administration (FDA) has...

09:30
Monteris Medical, a pioneer and leader in the emerging market for minimally invasive, image-guided laser ablation systems, announced that the favorable results of its LAASR (Laser Ablation After Stereotactic Radiosurgery) clinical study have been...

09:00
Israeli biotechnology company Kadimastem announces the approval by the European Union and the Israel Innovation Authority, to receive a joint research grant under the Eurostars program, for the clinical development of the company's technology for...

09:00
Nyxoah S.A., a medical device company focused on the development and commercialization of a best-in-class hypoglossal nerve stimulation (HGNS) therapy for the treatment of Obstructive Sleep Apnea (OSA), announced today that it successfully raised an...

08:30
Theravance Biopharma, Inc. ("Theravance Biopharma") today highlighted that the European Commission authorized an expanded label for once-daily Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol 'FF/UMEC/VI'), recognizing the product's...

08:01
Surgery performed at NYU Langone Orthopedic Hospital in New York by sports medicine surgeon Eric Strauss, MD CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions, announced today the successful...

08:00
NeoLight, an empathy-driven medical device company that designs, engineers, and manufactures technologies to treat infants with life-threatening medical conditions, announces today interim data from an ongoing clinical study on the efficacy of...

08:00
NGM Biopharmaceuticals, Inc., a clinical stage biotechnology company focused on harnessing powerful biology to develop transformative therapeutics for patients, today announced preliminary results from a Phase 1b proof-of-concept clinical trial of...

07:30
Tris Pharma, Inc. (Tris), a biopharmaceutical company focused on developing innovative products that deliver meaningful patient benefits, today announced that it presented four scientific posters on DYANAVEL XR at the 2018 NEI Congress in Orlando,...

07:08
SERAXIS Inc., a rapidly growing regenerative medicine company today announced the publication of important trial considerations for SR-01, its pluripotent stem cell-derived islet therapy for insulin-dependent diabetes. An...

07:08
Stéphane Le Roy has been appointed President Business Area Surgical Workflows and member of the Getinge Executive Team. Stéphane most recently held the position of Regional President of South West Europe, in Getinge. In his new role, Stéphane will be...

07:00
Leading researchers from the U.S., U.K., and Europe at a Swiss conference last month reported progress on incriminating several infectious agents as possible triggers of Alzheimer's disease, says Leslie Norins, MD, PhD, a speaker and CEO of...

06:00
Nyxoah S.A., a medical device company focused on the development and commercialization of a best-in-class hypoglossal nerve stimulation (HGNS) therapy for the treatment of Obstructive Sleep Apnea (OSA), announced today that it successfully raised an...

03:00
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that BBT-401, the first anti-Pellino-1 compound currently under development for ulcerative colitis (UC) treatment, proved its safety and...


11 novembre 2018

11:45
Novartis announced today results of the landmark PIONEER-HF trial showing that in-hospital initiation of Entresto tablets provided superior benefit compared to enalapril?a heart failure medication commonly used?in patients with HFrEF who had been...

10:32
Amarin Corporation plc , announced today the primary results from the Vascepa® (icosapent ethyl) cardiovascular (CV) outcomes trial, REDUCE-ITtm, following presentation of the late-breaking clinical trial results at the 2018 Scientific Sessions of...

08:14
Mortality risk reduction greater in patients treated for at least 3 years or those with baseline LDL-C levels of at least 100 mg/dL New analyses show reduction in non-fatal cardiovascular events is associated with a subsequent reduction in...


10 novembre 2018

17:37
The Association of Black Cardiologists (ABC), an inclusive organization dedicated to eliminating disparities in cardiovascular diseases, and Quantum Genomics, a biopharmaceutical company that developed a new drug class that directly targets the brain...

16:45
AstraZeneca today announced positive full results from the DECLARE-TIMI 58 cardiovascular (CV) outcomes trial (CVOT) for Forxiga (dapagliflozin). The data were presented as a late-breaking abstract (#19485) at the American Heart Association (AHA)...

16:45
AstraZeneca a annoncé aujourd'hui les résultats...

06:02
Infinity Pharmaceuticals, Inc. announced that data to be presented today at the 33rd Annual Meeting of the Society for Immunotherapy of Cancer (SITC) demonstrated preliminary evidence that IPI-549 in combination with Opdivo® (nivolumab) is...


9 novembre 2018

18:15
Nektar Therapeutics  announced today a presentation of new clinical and preclinical data for its I-O pipeline at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting.  New clinical study results from the PIVOT-02 Phase 1/2 Study were...

13:50
GS1 Ireland led an international coalition which successfully employed a sterile field scanner during surgery. The "TRACTUS" scanner by Matrix IT Medical Tracking Systems effectively collected detailed medical device information from extremely small...

11:01
Could our blood hold the molecular secrets to a fountain of youth, preventing age-related brain disorders? Are brain aging and Alzheimer's disease caused by a failure of interconnected systems in our bodies, triggering a domino-like cascade of...

11:00
The utility of imaging biomarkers in NASH is the focus of several abstracts accepted for presentation, here, at the American Association for the Study of Liver Disease's The Liver Meeting® 2018, November 9-13, 2018 (Booth #611). Three abstracts - two...

09:47
NGM Biopharmaceuticals, Inc., a clinical stage biotechnology company focused on harnessing powerful biology to develop transformative therapeutics for patients, today announced preliminary histology data from open-label, single-blind, dose-finding...

08:35
Mirati Therapeutics, Inc. , a clinical-stage targeted oncology company, announced preliminary biomarker data from the ongoing Phase 2 clinical trial of sitravatinib in combination with nivolumab (OPDIVO®) in non-small cell lung cancer (NSCLC)...

08:30
Mirati Therapeutics, Inc. , a clinical-stage targeted oncology company, announced data from the ongoing Phase 2 clinical trial of mocetinostat in combination with durvalumab (IMFINZI®) in non-small cell lung cancer (NSCLC) patients at the Society for...

08:09
Mallinckrodt plc , a leading global specialty pharmaceutical company, today announced results of a pooled analysis1 of terlipressin clinical trial data in patients with hepatorenal syndrome type 1 (HRS-1) at The Liver Meeting® 2018, the annual...

08:01
BioSpecifics Technologies Corp. , a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed as XIAFLEX® in the U.S. and Xiapex® in Europe, today announced...

08:01
Synthorx, Inc., a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for cancer and autoimmune disorders, today announced company researchers will present results...

08:00
AbbVie , a research-based global biopharmaceutical company, today announced it will present data from two studies that assessed HCV screening and diagnosis practices and linkage to care in the United States (US) at The Liver Meeting® 2018, the Annual...

08:00
TARIS® announced today the presentation of data detailing the natural history of patients with Muscle Invasive Bladder Cancer (MIBC) who do not receive potentially curative therapy. This research leveraged 17 years of longitudinal data from Sweden's...

08:00
Pliant Therapeutics, Inc., a biotechnology company unraveling and targeting the key biological pathways driving fibrosis, today announced company scientists and research collaborators will present in vivo data highlighting Pliant's clinical product...

08:00
Seal Rock Therapeutics, Inc., a discovery stage company developing best-in-class treatments for inflammatory and fibrotic diseases with no available therapies, today announced its lead compound, SRT-015, a differentiated inhibitor of apoptosis...

07:00
Leap Therapeutics, Inc. today presented clinical data from its ongoing Phase I/II study of DKN-01 in combination with paclitaxel in patients with advanced esophagogastric cancer at the Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting...

02:18
Innovent Biologics, Inc. (Innovent) (HKEX: 1801), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today presented clinical research data on cohort E from a Phase Ib clinical trial at the...

00:12
Alligator Bioscience , a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, and Aptevo Therapeutics Inc. , a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics,...

1 2 3 4 5 6 7 8 9 10